Teriflunomide Treatment Reduces B Cells in Patients With MS

Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000403
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-Ms Subjects

Frontiers in Neurology
Neurology
2018English

NHS to Fund Treatment for 10000 Patients With MS

BMJ
2002English

Antigen Specificity of Clonally Expanded and Receptor Edited Cerebrospinal Fluid B Cells From Patients With Relapsing Remitting MS

Journal of Neuroimmunology
AllergyImmunologyNeurology
2007English

Treatment of Hyperprolactinaemia Reduces Total Cholesterol and LDL in Patients With Prolactinomas

Metabolic Brain Disease
BiochemistryMolecular NeuroscienceNeurologyCellular
2016English

Pre-Treatment With Mesenchymal Stem Cells Reduces Ventilator-Induced Lung Injury

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Hepatitis B Virus Treatment in Hepatocellular Carcinoma Patients Prolongs Survival and Reduces the Risk of Cancer Recurrence

Clinical and Experimental Hepatology
Hepatology
2018English

Exosome-Enriched Fractions From MS B Cells Induce Oligodendrocyte Death

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2019English

MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic forSle1and Human CD19

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2016English

Clostridium Butyricum in Combination With Specific Immunotherapy Converts Antigen-Specific B Cells to Regulatory B Cells in Asthmatic Patients

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy